Journal list Promote Sponsor
verified SJR 1,255 · Q1 • database Scopus / SJR & Web of Science indexed
Hematology/Oncology Clinics of North America
United States · W.B. Saunders
workspace_premium Q1 — Hematology lock Subscription

Hematology/Oncology Clinics of North America

Hematology/Oncology Clinics of North America is a journal indexed in SJR in Hematology and Oncology with an H index of 98. It has an SJR impact factor of 1,255 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,255.

Hematology/Oncology Clinics of North America focuses its scope in these topics and keywords: bloodless, ultimate, tool, blood, human, surgery, approach, emission, oncology, positron, ...

ISSN: 0889-8588
Publisher: W.B. Saunders
Category: Hematology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,255 Q1
H-index 98
Acceptance rate pie_chart
26% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,255

H-index

98

Docs (year)

95

Docs 3y

270

Total refs

6056

Cites 3y

802

Citable 3y

233

Cites/Doc 2y

2.59

Ref/Doc

63.75

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

BONE MARROW METASTASES

View more

UNRELATED DONOR TRANSPLANT THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA

View more

DIAMOND-BLACKFAN ANEMIA

View more

DIAGNOSIS AND MANAGEMENT OF SYSTEMIC NON-HODGKIN'S LYMPHOMA IN HIV DISEASE

View more

CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMA

View more

Critical Appraisal of Immunization Strategies for Prevention of Infection in the Compromised Host

View more

COAGULATION DISORDERS IN CANCER

View more

CLINICAL USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE COLONY-STIMULATING FACTOR IN NEUTROPENIA ASSOCIATED WITH MALIGNANCY

View more

CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY

View more

CLINICAL ASPECTS OF APLASTIC ANEMIA

View more

Chemotherapy for Advanced Epithelial Ovarian Cancer

View more

CHEMOTHERAPY AND NEUTROPENIA

View more
SHOW MORE ARTICLES

CAN SCREENING FOR EARLY-STAGE PROSTATE CANCER BE RATIONALIZED?

View more

ADJUVANT THERAPY FOR STAGE I AND II NON-SMALL CELL LUNG CANCER

View more

BONE DISORDERS IN SICKLE CELL DISEASE

View more

BIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIA

View more

BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES

View more

BIOLOGY AND MANAGEMENT OF AIDS-ASSOCIATED PRIMARY CNS LYMPHOMAS

View more

AUTOTRANSPLANTS IN MULTIPLE MYELOMA: PUSHING THE ENVELOPE

View more

AUTOLOGOUS TRANSPLANTATION FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

View more

ANOREXIA AND CACHEXIA, ASTHENIA, AND LETHARGY

View more

ANEMIA OF CANCER

View more

ALTERNATIVE (NON-P-GLYCOPROTEIN) MECHANISMS OF DRUG RESISTANCE IN NON-HODGKIN'S LYMPHOMA

View more

ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA

View more

FAQs